RECOVERY is an international clinical trial identifying treatments that may be beneficial for people hospitalised with pneumonia.
RECOVERY started in the UK in early 2020 as the Randomised Evaluation of COVID-19 Therapy, a clinical trial testing treatments for people admitted to hospital with COVID-19 pneumonia. Since then it has identified five life-saving treatments for COVID-19, and shown that several other commonly used treatments were not effective.
RECOVERY is now open at sites across Europe, Asia and Africa and in 2023 expanded to test treatments of other types of pneumonia including influenza and non-viral community-acquired pneumonia.
trial registrations
The RECOVERY Trial is registered at ISRCTN50189673
EU Clinical Trials Register: EudraCT 2020-001113-21
Clinical Trials.gov: NCT04381936